METLIFE ANNOUNCES FINAL RESULTS OF CASH TENDER OFFER FOR ITS SERIES B PREFERRED SHARES

NEW YORK, June 29, 2015 - MetLife, Inc. (NYSE: MET) announced today the final results of the tender offer for its 6.500% Non-Cumulative Preferred Stock, Series B (CUSIP No. 59156R603), par value $0.01 per share and liquidation preference $25.00 per share (the Series B Preferred Shares ), which expired at 12:00 midnight, New York City time, on June 26, 2015. The Series B Preferred Shares are listed on the NYSE under the symbol METPrB.

A total of 37,192,413 Series B Preferred Shares were properly tendered and not properly withdrawn.

MetLife intends to accept for purchase all Series B Preferred Shares properly tendered and not properly withdrawn, for $25.00 per Series B Preferred Share, plus an amount equal to accrued, unpaid and undeclared dividends from, and including, June 15, 2015 to, but excluding, June 29, 2015, the settlement date of the tender offer.

Based on these numbers, and following settlement of the tender offer, MetLife will have 22,807,587 Series B Preferred Shares issued and outstanding.

As previously announced, MetLife has delivered a notice of redemption to the holders of the Series B Preferred Shares. Any Series B Preferred Shares that are not purchased by MetLife in the tender offer will be redeemed by MetLife on July 1, 2015 at a redemption price of $25.00 per share, without any payment for accrued, unpaid and undeclared dividends on the Series B Preferred Shares from, and including, June 15, 2015 to, but excluding, the redemption date, pursuant to the terms of the Certificate of Designations for the Series B Preferred Shares. As a result of the redemption, the Series B Preferred Shares will be removed from listing on the NYSE on the redemption date.

Goldman, Sachs & Co. acted as the dealer manager in the tender offer. All inquiries about the tender offer should be directed to Goldman, Sachs & Co. at (800) 828-3182 (toll-free) or (212) 902-6595 (collect). Copies of the Offer to Purchase, dated June 1, 2015, as amended and supplemented on June 12, 2015, the Letter of Transmittal, as amended and supplemented, or any related documents regarding the tender offer may be obtained from Global Bondholder Services Corporation, at (866) 470-3800 (toll-free) or, for banks and brokers (212) 430-3774 (collect).

THIS NEWS RELEASE IS FOR INFORMATIONAL PURPOSES ONLY AND IS NOT AN OFFER TO BUY OR THE SOLICITATION OF AN OFFER TO SELL ANY SERIES B PREFERRED SHARES. THE SOLICITATION OF OFFERS TO BUY SERIES B PREFERRED SHARES WERE ONLY MADE PURSUANT TO THE OFFER TO PURCHASE AND THE LETTER OF TRANSMITTAL, WHICH WERE DISTRIBUTED TO HOLDERS OF THE SERIES B PREFERRED SHARES. THOSE MATERIALS CONTAIN IMPORTANT INFORMATION, INCLUDING THE VARIOUS TERMS OF, AND CONDITIONS TO, THE TENDER OFFER. METLIFE HAS NOT AUTHORIZED ANY PERSON TO MAKE ANY RECOMMENDATION ON ITS BEHALF AS TO WHETHER HOLDERS SHOULD TENDER OR REFRAIN FROM TENDERING SERIES B PREFERRED SHARES IN THE TENDER OFFER. THIS NEWS RELEASE DOES NOT CONSTITUTE A NOTICE OF REDEMPTION OF THE SERIES B PREFERRED SHARES. HOLDERS OF THE SERIES B PREFERRED SHARES SHOULD REFER TO THE NOTICE OF REDEMPTION DELIVERED TO THE REGISTERED HOLDERS OF THE SERIES B PREFERRED SHARES BY COMPUTERSHARE, INC., THE REDEMPTION AGENT WITH RESPECT TO THE SERIES B PREFERRED SHARES.

About MetLife

MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ( MetLife ), is one of the largest life insurance companies in the world. Founded in 1868, MetLife is a global provider of life insurance, annuities, employee benefits and asset management. Serving approximately 100 million customers, MetLife has operations in nearly 50 countries and holds leading market positions in the United States, Japan, Latin America, Asia, Europe and the Middle East. For more information, visit www.metlife.com.

This news release may contain or incorporate by reference information that includes or is based upon forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give expectations or forecasts of future events. These statements can be identified by the fact that they do not relate strictly to historical or current facts. They use words such as anticipate, estimate, expect, project, intend, plan, believe and other words and terms of similar meaning, or are tied to future periods, in connection with a discussion of future operating or financial performance. In particular, these include statements relating to future actions, prospective services or products, future performance or results of current and anticipated services or products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, trends in operations and financial results.

Any or all forward-looking statements may turn out to be wrong. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many such factors will be important in determining the actual future results of MetLife, Inc., its subsidiaries and affiliates. These statements are based on current expectations and the current economic environment. They involve a number of risks and uncertainties that are difficult to predict. These statements are not guarantees of future performance. Actual results could differ materially from those expressed or implied in the forward-looking statements. Risks, uncertainties, and other factors that might cause such differences include the risks, uncertainties and other factors identified in MetLife, Inc.'s filings with the U.S. Securities and Exchange Commission (the SEC ). These factors include: (1) difficult conditions in the global capital markets; (2) increased volatility and disruption of the capital and credit markets, which may affect our ability to meet liquidity needs and access capital, including through our credit facilities, generate fee income and market-related r

LINK:	https://www.metlife.com/about/press-room/us-press-releases/2015/index....
	See more stories from metlife

Most recent headlines